Clinical Trial Update: Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating biomarkers of androgen response and resistance in patients with castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Castration-resistant Prostate Cancer | Phase 2 | Status: COMPLETED